Fundamentals of Rhenium-188 Radiopharmaceutical Chemistry
The β<sup>−</sup> emitter, rhenium-188 (<sup>188</sup>Re), has long been recognized as an attractive candidate for targeted cancer radionuclide therapy (TRNT). This transition metal shares chemical similarities with its congener element technetium, whose nuclear isomer techne...
Main Authors: | Janke Kleynhans, Adriano Duatti, Cristina Bolzati |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/3/1487 |
Similar Items
-
Rhenium Perrhenate (<sup>188</sup>ReO<sub>4</sub>) Induced Apoptosis and Reduced Cancerous Phenotype in Liver Cancer Cells
by: Samieh Asadian, et al.
Published: (2022-01-01) -
Radioactivity distribution in the blood and urine of patients receiving systemic therapy with a <sup>177</sup>Lu radiopharmaceutical and local (intra-articular) therapy with a <sup>188</sup>Re radiopharmaceutical
by: E. D. Stepchenkova, et al.
Published: (2022-12-01) -
Involvement of Differentially Expressed microRNAs in the PEGylated Liposome Encapsulated <sup>188</sup>Rhenium-Mediated Suppression of Orthotopic Hypopharyngeal Tumor
by: Bing-Ze Lin, et al.
Published: (2020-08-01) -
Concentration of Rhenium-188 for the Radiopharmaceutical Synthesis
by: A. O. Malysheva, et al.
Published: (2022-11-01) -
SYNTHESIS OF RADIOPHARMACEUTICAL WITH RHENIUM-188 AND LIPIODOL
by: G. E. Kodina, et al.
Published: (2019-01-01)